---
figid: PMC8894956__10.1177_17588359221082339-fig4
figtitle: 'First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for
  HER2-altered NSCLC: a retrospective real-world POLISH study'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8894956
filename: 10.1177_17588359221082339-fig4.jpg
figlink: /pmc/articles/PMC8894956/figure/fig4-17588359221082339/
number: F4
caption: Possible mechanism for immunosuppression in HER2-altered NSCLC mediated by
  the PI3 K/AKT signaling pathway.
papertitle: 'First-line immunotherapy or angiogenesis inhibitor plus chemotherapy
  for HER2-altered NSCLC: a retrospective real-world POLISH study.'
reftext: Guangjian Yang, et al. Ther Adv Med Oncol. 2022;14:17588359221082339.
year: '2022'
doi: 10.1177/17588359221082339
journal_title: Therapeutic Advances in Medical Oncology
journal_nlm_ta: Ther Adv Med Oncol
publisher_name: SAGE Publications
keywords: angiogenesis inhibitor | chemotherapy | HER2 alteration | immunotherapy
  | non-small-cell lung cancer | real-world study
automl_pathway: 0.951694
figid_alias: PMC8894956__F4
figtype: Figure
redirect_from: /figures/PMC8894956__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8894956__10.1177_17588359221082339-fig4.html
  '@type': Dataset
  description: Possible mechanism for immunosuppression in HER2-altered NSCLC mediated
    by the PI3 K/AKT signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNG
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - CGAS
  - STING1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - TBK1
  - IRF3
  - ERBB2
---
